Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Io Therapeutics
Entity

Io Therapeutics

Tracked across 1 events · 7 articles · First seen Aug 05, 2026 · Last active Aug 05, 2026

Sentiment
70
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 70
Tech
IRX4204 Promotes Alpha-Synuclein Clearance in Parkinson's
Impact: Io Therapeutics is the developer of IRX4204 and the primary beneficiary of the positive data, which supports its clinical program and potential future trials.
Aug 05, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Io Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.